title: Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
authors.affiliation: The Storr Liver Unit, Westmead's Millennium Institute, University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.
authors.forename: Claire Z
authors.initials: CZ
authors.lastname: Larter
authors.forename: Geoffrey C
authors.initials: GC
authors.lastname: Farrell
mesh_terms: D052242:Adiponectin / Q000097:blood*; D016207:Cytokines / Q000097:blood*; D005234:Fatty Liver / Q000097:blood* / Q000628:therapy; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008019:Life Style; D011379:Prognosis; D015431:Weight Loss
chemical_list: D052242:Adiponectin; D016207:Cytokines